Bank of Nova Scotia Lowers Stock Holdings in Astera Labs, Inc. $ALAB

Bank of Nova Scotia cut its stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 50.4% during the second quarter, HoldingsChannel.com reports. The fund owned 478,000 shares of the company’s stock after selling 486,400 shares during the quarter. Bank of Nova Scotia’s holdings in Astera Labs were worth $43,221,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Oliver Lagore Vanvalin Investment Group purchased a new stake in shares of Astera Labs in the second quarter valued at approximately $29,000. Bernard Wealth Management Corp. bought a new stake in Astera Labs during the 2nd quarter valued at $36,000. Clearstead Trust LLC lifted its holdings in shares of Astera Labs by 46,100.0% in the 2nd quarter. Clearstead Trust LLC now owns 462 shares of the company’s stock worth $42,000 after buying an additional 461 shares during the period. Advisors Asset Management Inc. lifted its holdings in shares of Astera Labs by 68.6% in the 2nd quarter. Advisors Asset Management Inc. now owns 477 shares of the company’s stock worth $43,000 after buying an additional 194 shares during the period. Finally, Manchester Capital Management LLC grew its position in shares of Astera Labs by 141.5% during the 2nd quarter. Manchester Capital Management LLC now owns 483 shares of the company’s stock worth $44,000 after buying an additional 283 shares in the last quarter. Institutional investors own 60.47% of the company’s stock.

Insider Buying and Selling at Astera Labs

In related news, General Counsel Philip Mazzara sold 10,000 shares of the company’s stock in a transaction on Wednesday, October 1st. The stock was sold at an average price of $192.16, for a total value of $1,921,600.00. Following the transaction, the general counsel directly owned 151,573 shares of the company’s stock, valued at $29,126,267.68. This represents a 6.19% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Jitendra Mohan sold 90,459 shares of Astera Labs stock in a transaction dated Monday, November 17th. The stock was sold at an average price of $144.69, for a total value of $13,088,512.71. Following the sale, the chief executive officer directly owned 2,080,418 shares of the company’s stock, valued at approximately $301,015,680.42. This represents a 4.17% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 586,936 shares of company stock worth $89,331,140 in the last three months. 12.50% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on ALAB. Weiss Ratings restated a “hold (c-)” rating on shares of Astera Labs in a report on Wednesday, October 8th. Cowen restated a “hold” rating on shares of Astera Labs in a report on Wednesday, November 5th. TD Cowen lowered their price target on shares of Astera Labs from $225.00 to $170.00 and set a “hold” rating for the company in a research report on Wednesday, November 5th. Northland Capmk raised shares of Astera Labs from a “hold” rating to a “strong-buy” rating in a report on Monday, November 17th. Finally, Raymond James Financial started coverage on shares of Astera Labs in a research note on Friday, November 21st. They issued a “hold” rating for the company. One research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and eight have given a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $187.06.

Astera Labs Price Performance

Shares of NASDAQ:ALAB opened at $175.74 on Tuesday. The business’s 50-day moving average is $169.55 and its 200 day moving average is $152.10. Astera Labs, Inc. has a 1 year low of $47.13 and a 1 year high of $262.90. The firm has a market capitalization of $29.68 billion, a P/E ratio of 158.32, a P/E/G ratio of 3.00 and a beta of 1.52.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings results on Tuesday, November 4th. The company reported $0.49 earnings per share for the quarter, topping analysts’ consensus estimates of $0.39 by $0.10. The business had revenue of $230.58 million for the quarter, compared to analyst estimates of $206.42 million. Astera Labs had a return on equity of 13.48% and a net margin of 27.50%.The company’s revenue was up 103.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.23 earnings per share. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. On average, analysts expect that Astera Labs, Inc. will post 0.34 EPS for the current year.

Astera Labs Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.